文献速递心血管MRDSA

比较心脏磁共振引导与血管造影引导治疗稳定性冠心病患者:前瞻性随机对照试验结果

Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-01-01

该前瞻性随机对照试验纳入200例有症状的稳定性冠心病患者,随机分为诊断性冠状动脉造影组(第1组)或腺苷负荷心脏磁共振组(第2组)。主要终点为心源性死亡和非致命性心肌梗死的复合终点,12个月随访时第1组事件率3.1%、第2组4.2%,差异无统计学意义(p=0.72);第2组血运重建率较低(28.1% vs 45.9%)且1年后生活质量改善更显著。基于心脏磁共振的管理策略安全,但非劣效性未能证明。

要点

  • 稳定性冠心病患者采用腺苷负荷心脏磁共振指导管理安全,可减少血运重建操作。
  • 12个月主要终点事件率第1组3.1% vs 第2组4.2%,差异无统计学意义(p=0.72)。
  • 心脏磁共振组1年后生活质量较血管造影组显著改善。

核心结论

  • 基于心脏磁共振的管理策略对稳定性冠心病患者安全,减少血运重建操作,12个月随访时生活质量更优,但非劣效性未能证明。

研究设计与样本

  • 前瞻性随机对照试验(MAGnet,NCT02580851),纳入200例有症状的稳定性冠心病患者,随机分为诊断性冠状动脉造影组(第1组)或腺苷负荷心脏磁共振组(第2组),主要终点为心源性死亡和非致命性心肌梗死的复合终点,采用西雅图心绞痛问卷评估生活质量。

临床应用与阅片要点

  • 第1组45例(45.9%)行血运重建,第2组27例(28.1%)因心脏磁共振显示缺血而转诊血运重建。
  • 12个月随访时第1组3例(事件率3.1%) vs 第2组4例(事件率4.2%)发生主要终点事件,差异无统计学意义(p=0.72)。
  • 随后2年内第1组4例 vs 第2组9例事件(事件率4.1% vs 9.4%;p=0.25)。
  • 第2组1年后生活质量较第1组显著改善。

局限性

  • 非劣效性未能证明。
  • 最佳再评估时机有待研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was the prospective and randomized evaluation of cardiovascular endpoints and quality of life in patients with stable coronary artery disease comparing a cardiac magnetic resonance (CMR)-based management strategy with a coronary angiography-based approach.

BACKGROUND: Evidence from trials prospectively evaluating the role of CMR in clinical pathways and decision processes is limited.

METHODS: Patients with symptomatic CAD were randomized to diagnostic coronary angiography (group 1) or adenosine stress CMR (group 2). The primary endpoint was the composite of cardiac death and nonfatal myocardial infarction. Quality of life was assessed using the Seattle Angina Questionnaire at baseline and during follow-up.

RESULTS: Two hundred patients were enrolled. In group 1, 45 revascularizations (45.9%) were performed. In group 2, 27 patients (28.1%) were referred to revascularization because of ischemia on CMR. At 12-month follow-up, 7 primary events occurred: 3 in group 1 (event rate 3.1%) and 4 in group 2 (event rate 4.2%), with no statistically significant difference (p = 0.72). Within the next 2 years, 6 additional events could be observed, giving 4 events in group 1 and 9 events in group 2 (event rate 4.1% vs. 9.4%; p = 0.25). Group 2 showed significant quality-of-life improvement after 1 year in comparison to group 1.

CONCLUSIONS: A CMR-based management strategy for patients with stable coronary artery disease was safe, reduced revascularization procedures, and resulted in better quality of life at 12-month follow-up, though noninferiority could not be proved. Optimal timing for reassessment remains to be investigated. (Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention [MAGnet]; NCT02580851).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Buckert D, Witzel S, Steinacker JM, et al. Comparing Cardiac Magnetic Resonance-Guided Versus Angiography-Guided Treatment of Patients With Stable Coronary Artery Disease: Results From a Prospective Randomized Controlled Trial. JACC Cardiovasc Imaging. 2018. PMID: 29976305. doi:10.1016/j.jcmg.2018.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。